BRONCHIOLITIS OBLITERANS
Clinical trials for BRONCHIOLITIS OBLITERANS explained in plain language.
Never miss a new study
Get alerted when new BRONCHIOLITIS OBLITERANS trials appear
Sign up with your email to follow new studies for BRONCHIOLITIS OBLITERANS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug for Post-Transplant lung disease shows early safety signals
Disease control TerminatedThis early-stage study tested the safety of a drug called itacitinib in 8 adults who developed bronchiolitis obliterans syndrome (a type of lung scarring) after a donor stem cell transplant. The drug works by blocking certain enzymes that may contribute to lung damage. The study …
Matched conditions: BRONCHIOLITIS OBLITERANS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Can a simple inhaler prevent lung damage in child transplant survivors?
Disease control TerminatedThis study looked at whether an inhaled combination of fluticasone and salmeterol (common asthma drugs) could help children aged 6–17 whose lung function dropped after a stem cell transplant. The goal was to prevent a serious lung condition called bronchiolitis obliterans. The tr…
Matched conditions: BRONCHIOLITIS OBLITERANS
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Lung transplant drug trial halted: new inhaled therapy shows promise but study ends early
Disease control TerminatedThis study tested an inhaled form of cyclosporine A (L-CsA) plus standard care in 164 people who had a lung transplant and developed bronchiolitis obliterans, a condition that scars the small airways. The goal was to see if the treatment could slow lung function decline over 24 t…
Matched conditions: BRONCHIOLITIS OBLITERANS
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated May 11, 2026 20:40 UTC